Trial Profile
A phase II trial of inotuzumab ozogamicin in pediatric patients with acute B-cell lymphoblastic leukemia (ALL)
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 29 Nov 2015
Price :
$35
*
At a glance
- Drugs Inotuzumab ozogamicin (Primary)
- Indications Precursor cell lymphoblastic leukaemia-lymphoma
- Focus Therapeutic Use
- 29 Nov 2015 New trial record